Fabrício de Vargas Arigony Braga

Fabrício de Vargas Arigony Braga

Auto-generated profile, based on publicly available information

Fabrício de Vargas Arigony Braga

Universidade Federal de Pelotas, Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
CTC.J.F. Trindade
C.J.F. Trindade
BCBRUNA DA ROSA CURCIO
BRUNA DA ROSA CURCIO
FBF.V.A. Braga
F.V.A. Braga
PDP.B.J. Dallmann
P.B.J. Dallmann
MLMicael Feliciano Machado Lopes
Micael Feliciano Machado Lopes
CNCarlos Eduardo Wayne Nogueira
Carlos Eduardo Wayne Nogueira
Uveitis is the most common ocular alteration in septic foals. Despite its importance, its detection still is a challenge for equine clinicians, and survived foals can maintain ophthalmic sequelae if not briefly treated. This report aims to describe ophthalmic findings and the outcome in nine septic foals at Pelotas University Veterinary Hospital (HCV-UFPel). All patients were diagnosed with sepsis according to clinic and laboratorial parameters. The main uveitis findings were conjunctival hyperemia, fibrin and flare in anterior chamber, iris change of color, low intraocular pressure. Topically, the election treatment for all foals was two eye drops of Prednisolone 1%, with varied frequency, until recovery of ophthalmic parameters. There was 66% of favorable recuperation in total foals and 100% of visual recovery in survived foals, with complete ocular pathway transparency. This report shows that in the foals where systemic disease recovery occurred, a proper and early topical treatment of uveitis could lead to good visual prognosis.

9 March 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
LSLiliane Cristina Jerônimo dos Santos
Liliane Cristina Jerônimo dos Santos
EBEduarda Santos Bierhals
Eduarda Santos Bierhals
ASAlan Carlos de Santana
Alan Carlos de Santana
PWPéter de Lima Wachholz
Péter de Lima Wachholz
VFVitória Ramos de Freitas
Vitória Ramos de Freitas
PVPatrícia Silva Vives
Patrícia Silva Vives
As hérnias peritoneopericárdicas (HDPP) são anomalias anatômicas do desenvolvimento do diafragma e pericárdio que podem estar associadas com outras alterações congênitas concomitantemente. O objetivo deste relato foi descrever um caso de hérnia peritoneopericárdica associada à hérnia umbilical e úraco persistente atendido em Pelotas/RS, além de revisar os aspectos clínicos, meios de diagnósticos e tratamento acerca do assunto, uma vez que se trata de um caso raro. O cão, macho, SRD, com sete meses de idade, pesando 22kg foi atendido no Hospital de Clínicas Veterinárias da Universidade Federal de Pelotas por apresentar dispneia recorrente e aumento de volume em região umbilical. Através de radiografia de tórax e ecocardiograma foi diagnosticada a HDPP. O paciente foi submetido à celiotomia pré-umbilical e herniorrafias para correção das afecções. O mesmo não apresentou complicações durante o período pós-cirúrgico. O estudo de casos como o acima descrito é deveras importante para um melhor mapeamento de predisposições e condições associadas em afecções congênitas, uma vez em que podem acarretar complicações agudas e/ou crônicas, colocando em risco a vida de cães e gatos.

1 January 2026 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
LML. Marins
L. Marins
FBF.V.A. Braga
F.V.A. Braga
MFM. Furtado
M. Furtado
RSR. Silveira
R. Silveira
MVM.T. Vieira
M.T. Vieira
MCMarcio Nunes Correa
Marcio Nunes Correa
Infectious Bovine Keratoconjunctivitis (IBK) is the most prevalent ocular disease in cattle herds worldwide. The primary etiological agent is Moraxella bovis, a bacterium that adheres to the corneal epithelial cells. Due to its high contagiousness, IBK has significant impacts on animal health and welfare, as well as economic losses. The present study reports the case of a Hereford calf presenting lesions in both eyes. Upon examination, clinical signs such as keratitis, corneal opacity, corneal ulceration, and melting were detected in the left eye. In the right eye, corneal perforation was observed. Additionally, the animal exhibited progressive weight loss, impaired vision, and difficulty in locomotion and feeding. The treatment was performed topically using ophthalmic solutions containing ciprofloxacin, acetylcysteine, and homologous serum. Corneal re-epithelialization of the left eye occurred within 30 days. Subsequently, antibiotic therapy was discontinued, and treatment continued with eye drops containing dexamethasone. At 45 days after the initiation of treatment, clinical resolution was achieved, with recovery of vision in the left eye. The topical treatment was successful, and the animal returned to normal behavior, locomotion, and feeding patterns.

1 June 2019 in Pubvet
Verified
Journal Article
Open access
PDF file
PVPatrícia Silva Vives
Patrícia Silva Vives
MZMarina Zanin
Marina Zanin
TETainá Ança Evaristo
Tainá Ança Evaristo
FJFrancisco de Assis Araújo Camelo Júnior
Francisco de Assis Araújo Camelo Júnior
LDLuana Harz Durate
Luana Harz Durate
FBFabrício de Vargas Arigony Braga
Fabrício de Vargas Arigony Braga
Linfoma é a neoplasia linfo-hematopoiética mais frequente em cães, e uma das mais quimiorresponsivas na medicina veterinária, portanto o tratamento geralmente é baseado em protocolos quimioterápicos, associados ou não, a ressecção cirúrgica. Na forma alimentar, é pouco comum em cães e caracteriza-se pela localização no trato gastrointestinal e/ou linfonodos mesentéricos e aqueles não tratados vivem entre quatro a seis semanas após o início dos sinais clínicos ou diagnóstico. Este trabalho tem como objetivo relatar o tratamento cirúrgico de um cão jovem com linfoma intestinal obstrutivo, que após enterectomia do segmento acometido, obteve diagnóstico histopatológico. Mesmo com a prescrição de quimioterapia, o tutor optou pelo tratamento de suporte apenas e o paciente teve sobrevida de oito semanas.

30 March 2026 in Ars Veterinaria
Verified
Journal Article
Open access
EBE. T. Barwaldt
E. T. Barwaldt
FBF. V. A. Braga
F. V. A. Braga
SLS. R. L. Ladeira
S. R. L. Ladeira
MRMariana Cristina Hoeppner Rondelli
Mariana Cristina Hoeppner Rondelli
MCM. B. Cleff
M. B. Cleff
SJS. Jorge
S. Jorge
This study aimed to characterize and evaluate the antimicrobial susceptibility profile of bacterial agents isolated from corneal ulcers in dogs and cats diagnosed with ulcerative keratitis treated at the Veterinary Teaching Hospital of the Federal University of Pelotas (HCV/UFPel). The study was conducted between November 20, 2022, and January 20, 2024, and included 19 dogs and one cat presenting ulcerative keratitis with varying degrees of severity. Following topical application of an ophthalmic anesthetic solution, 20 samples were collected from both healthy and ulcerated corneal surfaces using sterile swabs, which were subsequently placed in Stuart transport medium until laboratory processing. Bacterial isolation and characterization were performed, as well as antimicrobial susceptibility testing against drugs commonly used in veterinary ophthalmology. Bacterial growth was observed in 52.6% of canine samples, while no growth was detected in the feline sample. Among the isolates, 90% were Gram-positive and 10% Gram-negative bacteria, with Staphylococcus spp. (50%) being the most prevalent genus. Norfloxacin and chloramphenicol showed the highest efficacy against Gram-positive isolates. In the Gram-negative group, Escherichia coli was the only species identified and did not exhibit full susceptibility to any of the tested antimicrobials. Notably, bacterial resistance of up to 40% to amikacin was observed in both Gram-positive and Gram-negative isolates. These findings emphasize the importance of microbiological identification and antimicrobial susceptibility testing for the rational selection of topical antimicrobial therapies in cases of ulcerative keratitis, aiming to improve therapeutic efficacy and reduce the risk of bacterial resistance.